Welcome to the Angiogenesis Foundation's Patient Cancer Center
The Angiogenesis Foundation is educating patients about the role of angiogenesis in cancer and about antiangiogenic medicines that are being developed to control this disease. Our information comes from the Foundation's databases as well as from our network of leading oncologists, cancer researchers, biopharmaceutical companies, governmental resources, and patient advocacy groups.
FDA-Approved Antiangiogenic Drugs
Natural and Complementary Therapies
Angiogenesis in Cancer
Every cancer begins its existence as a tiny cluster of abnormal tumor
cells growing in an organ. Without its own blood supply to bring in oxygen
and nutrients, the tumor cannot grow larger than 1-2 millimeters in diameter
(about the size of a small pea). While this early stage of tumor growth
can last for month or even years, eventually a few cancer cells gain the
ability to produce proteins known as angiogenic growth factors. These
'growth factors' are released by the tumor into nearby tissues, and they
stimulate new blood vessels to sprout vigorously from existing healthy
blood vessels, into the tumor.
Once new blood vessels enter the tumor: